Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

BioChemanalysis Corporation (AKA: BioChem Analysis Corp)
Profile last edited on: 12/29/14      CAGE: 440B5      UEI:

Business Identifier: Stable non-radioactive isotopes to biomedical research
Year Founded
1992
First Award
1993
Latest Award
2014
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2201 West Campbell Park Drive Suite 28
Chicago, IL 60612
   (312) 243-5988
   N/A
   N/A
Location: Single
Congr. District: 07
County: Cook

Public Profile

BioChemAnalysis Corp. provides biotechnology research consulting and research and development services focusing on the use of diagnostic methods for nonradioactive isotopes and non-invasive methods to assess skeletal muscle loss and insulin resistance. The firm also provides research consulting.

Extent of SBIR involvement

User Avatar
Phase I Awards
16
Phase II Awards
5
Conversion Rate
31.25%
Phase I Dollars
$2,247,118
Phase II Dollars
$3,918,551
Total Awarded
$6,165,669

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2014 2 NIH $1,113,129
Project Title: Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients
2011 2 NIH $1,063,169
Project Title: Non-invasive Assessment of Insulin Resistance
2008 1 NIH $204,345
Project Title: A Non-Invasive Surrogate Test Of Ogtt To Screen For Pre-Diabetes
2005 1 NIH $199,176
Project Title: Long-term Iron Needs of Renal Transplant Recipients
2005 1 NIH $198,623
Project Title: A Test of Iron Malabsorption in Patients with IDA

Key People / Management

  Morteza Janghorbani -- President

  Sally Schuette -- Vice President

  Dorothy Waite -- Vice President

Company News

There are no news available.